Article
A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis.
Antimicrobial agents and chemotherapy - 1 Dec 1997
Lety M A, Nair S, Berche P, Escuyer V
Abstract excerpt
Ethambutol [EMB; dextro-2,2'-(ethylenediimino)-di-1-butanol] is an effective drug when used in combination with isoniazid for the treatment of tuberculosis. It inhibits the polymerization of arabinan in the arabinogalactan and lipoarabinomannan of the mycobacterial cell wall. Recent studies have shown that arabinosyltransferases could be targets of EMB. These enzymes are encoded by the emb locus that was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
